Sree Pharma Solution Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 17 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -33.34%
- Profit Growth 317.53%
- Ebitda -247.34%
- Net Worth 37.93%
- Total Assets -36.08%
About Sree Pharma Solution
Sree Pharma Solution Private Limited (SPSPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 January 2010 and has a history of 15 years. Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Subir Dutta and Kalyan Ghosh serve as directors at the Company.
Company Details
-
Location
24 Parganas, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232WB2010PTC141050
-
Company No.
141050
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Jan 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Sree Pharma Solution?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subir Dutta
|
Director | 17-Jul-2018 | Current |
|
Kalyan Ghosh
|
Director | 11-Jun-2018 | Current |
Financial Performance of Sree Pharma Solution.
Sree Pharma Solution Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 33.34% decrease. The company also saw a substantial improvement in profitability, with a 317.53% increase in profit. The company's net worth Soared by an impressive increase of 37.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sree Pharma Solution?
In 2015, Sree Pharma Solution had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Karunamoyee Construction Private LimitedSubir Dutta and Kalyan Ghosh are mutual person
-
Bidlastar Commercial Private Limited
Subir Dutta is a mutual person
-
Midland Nursing Home Private Limited
Subir Dutta and Kalyan Ghosh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sree Pharma Solution?
Unlock and access historical data on people associated with Sree Pharma Solution, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sree Pharma Solution, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sree Pharma Solution's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
